3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Prostatic Neoplasms
2
Lung Neoplasms
2
Recurrence
1
Pancreatic Neoplasms
1
Neoplastic Cells, Circulating
1
Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Gallbladder Neoplasms
1
Colonic Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Brain Edema
1
Adenocarcinoma
1
Interventions
Propofol
3
Oxaliplatin
3
Morphine
3
Fentanyl
3
Sevoflurane
2
Ropivacaine
2
Fluorouracil
2
Capecitabine
2
Bupivacaine
2
Bevacizumab
2
Acetaminophen
2
polyethylene glycol 3350
1
oxycodone-acetaminophen
1
gatorade
1
fish oil triglycerides
1
Vitamin D
1
Tranexamic Acid
1
Tramadol
1
Tegafur
1
Sodium Chloride
1
Simethicone
1
Saline Solution
1
Rivaroxaban
1
Polyethylene Glycols
1
Pirinitramide
1
Panitumumab
1
Orphenadrine
1
Neuroleptanalgesia
1
Midazolam
1
Methadone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Colonic Neoplasms
×
Desflurane
×
Clear all
NCT04074460
2022-06-09
VAPOR-C
Peter MacCallum Cancer Centre, Australia
Phase 4
Completed
169 enrolled